Originally produced for the Innovation Economy Council (IEC), this research examines the state of the Canadian cell and gene therapy sector and what needs to be done to help it grow. The IEC is now The Conference Board of Canada’s Canadian Centre for the Innovation Economy (CCIE).
What is the significance of cell and gene therapy in the field of modern medicine, and how does it differ from conventional drug treatments? What are the potential economic benefits and opportunities associated with developing a strong cell and gene therapy manufacturing industry in Canada? How does the Canadian government’s focus on rebuilding vaccine-making capacity during the COVID-19 pandemic potentially impact the development of the cell and gene therapy industry?
Read the research for the full analysis.
There are no reviews yet.